PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33644593-0	2021	Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-kappaB Pathway.	Feprazone	0-9	nuclear factor kappa B subunit 1	Homo sapiens	121-130	
33644593-9	2021	Our results also demonstrate that feprazone prevented FFA-induced activation of the toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor kappa-B (NF-kappaB) signaling pathway.	Feprazone	34-43	nuclear factor kappa B subunit 1	Homo sapiens	178-187	
33869924-12	2021	Interestingly, Feprazone prevented the activation of nuclear factor kappa-B (NF-kappaB) by preventing nuclear translocation of NF-kappaB p65 and the luciferase activity of the NF-kappaB promoter.	Feprazone	15-24	nuclear factor kappa B subunit 1	Homo sapiens	53-75	
33869924-12	2021	Interestingly, Feprazone prevented the activation of nuclear factor kappa-B (NF-kappaB) by preventing nuclear translocation of NF-kappaB p65 and the luciferase activity of the NF-kappaB promoter.	Feprazone	15-24	nuclear factor kappa B subunit 1	Homo sapiens	77-86	
33869924-12	2021	Interestingly, Feprazone prevented the activation of nuclear factor kappa-B (NF-kappaB) by preventing nuclear translocation of NF-kappaB p65 and the luciferase activity of the NF-kappaB promoter.	Feprazone	15-24	nuclear factor kappa B subunit 1	Homo sapiens	127-136	
33869924-14	2021	Importantly, silencing of Nrf2 abolished the protective effects of Feprazone against IL-1beta-induced NF-kappaB activation and cellular senescence.	Feprazone	67-76	nuclear factor kappa B subunit 1	Homo sapiens	102-111